Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polar Capital Global Healthcare Trust is a London-based investment trust that focuses on generating capital growth by investing in a global portfolio of healthcare stocks. Managed by Polar Capital LLP, the trust invests across various sub-sectors including pharmaceuticals, biotechnology, healthcare equipment, and managed healthcare. The portfolio typically includes major industry leaders such as AstraZeneca, Eli Lilly, and UnitedHealth Group, as well as smaller innovative biotech firms. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Power Capital.